Fig. 3From: Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based studyCumulative Incidence for OAC Switches. Refer to Additional File 3 to see the ‘Switched from Apixaban’ graph with a y-axis scale up to 10%Back to article page